Primaquine for plasmodium vivax malaria treatment – authors' reply

Primaquine for plasmodium vivax malaria treatment – authors' reply

Opis bibliograficzny
Główni autorzy:	Price, RN, Taylor, WRJ, Thriemer, K, White, NJ, Day, NP
Format:	Journal article
Język:	English
Wydane:	Elsevier 2020

Podobne zapisy

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
od: Setyadi, A, i wsp.
Wydane: (2019)

Higher-dose primaquine to prevent relapse of Plasmodium vivax malaria
od: Watson, JA, i wsp.
Wydane: (2022)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency
od: Taylor, WRJ, i wsp.
Wydane: (2023)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia
od: Thriemer, K, i wsp.
Wydane: (2020)

Treatment of primaquine-resistant Plasmodium vivax malaria.
od: Luzzi, G, i wsp.
Wydane: (1992)

TREATMENT OF PRIMAQUINE-RESISTANT PLASMODIUM-VIVAX MALARIA
od: Luzzi, G, i wsp.
Wydane: (1992)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
od: Agus Setyadi, i wsp.
Wydane: (2019-04-01)

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis
od: Fadilah, I, i wsp.
Wydane: (2024)

Expanding the use of primaquine for the radical cure of Plasmodium vivax
od: Price, RN, i wsp.
Wydane: (2018)

Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
od: Watson, J, i wsp.
Wydane: (2019)

Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria.
od: Pukrittayakamee, S, i wsp.
Wydane: (1994)

The risk of adverse clinical outcomes following treatment of Plasmodium vivax malaria with and without primaquine in Papua, Indonesia.
od: Kamala Thriemer, i wsp.
Wydane: (2020-11-01)

Determinants of primaquine and carboxyprimaquine exposures in children and adults with Plasmodium vivax malaria
od: Chu, CS, i wsp.
Wydane: (2021)

Plasmodium vivax Malaria Relapses after Primaquine Prophylaxis
od: Pavani Reddy, i wsp.
Wydane: (2006-11-01)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
od: Taylor, WRJ, i wsp.
Wydane: (2021)

A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand.
od: Pukrittayakamee, S, i wsp.
Wydane: (2010)

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial
od: Taylor, WRJ, i wsp.
Wydane: (2019)

Tafenoquine versus primaquine to prevent relapse of Plasmodium vivax malaria
od: Llanos-Cuentas, A, i wsp.
Wydane: (2019)

The prevention and treatment of Plasmodium vivax malaria
od: Chu, CS, i wsp.
Wydane: (2021)

Therapeutic principles of primaquine against relapse of Plasmodium vivax malaria
od: Baird, J
Wydane: (2018)

Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis
od: Rajasekhar, M, i wsp.
Wydane: (2023)

Therapeutic Responses of Plasmodium vivax Malaria to Chloroquine and Primaquine Treatment in Northeastern Myanmar.
od: Yuan, L, i wsp.
Wydane: (2014)

Therapeutic efficacy of chloroquine and primaquine for <it>Plasmodium vivax</it> malaria treatment in southeast Iran
od: Heidari Aliehsan, i wsp.
Wydane: (2012-10-01)

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
od: Yilma, D, i wsp.
Wydane: (2023)

Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study
od: Douglas, NM, i wsp.
Wydane: (2017)

Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
od: Walter R J Taylor, i wsp.
Wydane: (2023-09-01)

High-dose primaquine regimens against relapse of Plasmodium vivax malaria.
od: Krudsood, S, i wsp.
Wydane: (2008)

Comparison of the umulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in Plasmodium vivax malaria
od: Chu, C, i wsp.
Wydane: (2018)

Comparison of the cumulative efficacy and safety of chloroquine, artesunate, and chloroquine-primaquine in plasmodium vivax malaria
od: Chu, C, i wsp.
Wydane: (2018)

Primaquine radical cure of Plasmodium vivax: a critical review of the literature.
od: John, G, i wsp.
Wydane: (2012)

Diagnosis and treatment of Plasmodium vivax malaria
od: Baird, J, i wsp.
Wydane: (2016)

Primaquine as anti-relapse therapy for Plasmodium vivax
od: Baird, J
Wydane: (1998)

Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia
od: Getachew, S, i wsp.
Wydane: (2015)

Severe hemolysis during primaquine radical cure of Plasmodium vivax malaria: two systematic reviews and individual patient data descriptive analyses
od: Yilma, D, i wsp.
Wydane: (2021)

Treatment of chloroquine-resistant Plasmodium vivax with chloroquine and primaquine or halofantrine.
od: Baird, J, i wsp.
Wydane: (1995)

Can primaquine therapy for vivax malaria be improved?
od: Baird, J, i wsp.
Wydane: (2003)

Mass primaquine treatment to eliminate vivax malaria: Lessons from the past
od: Kondrashin, A, i wsp.
Wydane: (2014)

Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border.
od: Takeuchi, R, i wsp.
Wydane: (2010)

Low risk of recurrence following artesunate-Sulphadoxine-pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan
od: Hamid, MMA, i wsp.
Wydane: (2018)

Diagnosis and treatment of Plasmodium vivax malaria.
od: Baird, K, i wsp.
Wydane: (2012)